Global equities hit by hawkish Fed, Aviva results cheered

Global equities were deep in the red on Thursday after the Federal Reserve Chair concluded a materially hawkish testimony to Congress and raised concerns of higher interest rates for longer.

The FTSE 100 was down 0.7% to 7,876 at the time of writing while the German DAX shed 0.4%. US futures were pointing to a lower open.

“The FTSE 100 took another step back on Thursday as a second day of testimony in front of Washington lawmakers by Federal Reserve chair Jerome Powell largely stuck to the hawkish tone of the previous day,” said AJ Bell investment director Russ Mould.

“While Powell softened things a little by saying nothing is decided yet, the clear message is future rate decisions will be dependent on the data and for now that seems to be tilting things more towards a 50-basis point rather than 25 basis point rate rise later this month.

“This would shatter the market’s comfortable illusion at the start of the year that rates were about to pivot and a soft landing for the US economy could be engineered.”

US 10-year Bond yields briefly touched 4%, before falling. A higher yield in US treasuries made the FTSE 100’s bond proxy stocks seem less attractive with companies including British Land, Land Securities, SSE and Whitbread falling.

Aviva

Through the gloom of the UK’s miserable weather conditions and generally negative stock markets, Aviva was a ray of light after reporting strong results for 2022. Operating profit jumped 35% to £2.2bn and the company rewarded investors with a share buyback and dividend hike.

“For investors, news of a £300m buyback was welcomed with open arms – the capital position remains strong, and the potential for further buybacks alongside a 7.8% forward yield looks attractive,” said Matt Britzman, equity analyst at Hargreaves Lansdown.

Cyclical selloff

It was a tough day for the FTSE 100’s cyclical stocks. The prospect of tighter monetary policy for an extended period damped demand for companies reliant on stronger economic conditions. The miners were down heavily. Rio Tinto dropped 4.8% while Endeavour Mining tanked 5.6% after reporting 2022 results.

Entain shares dip on European regulatory warning

The outlook for Entain in 2023 has caused concerns among investors on Thursday as group profit after tax dumped 88% to £33m due to amortisation of acquired intangibles and exceptional costs.

Underlying EBITDA grew 13% to £993.2m.

The company’s own warnings of regulatory headwinds in 2023 may prove a hurdle for higher profits in the coming year as the group pins hopes on growth in the US.

The group’s 50% stake in US joint venture BetMGM enjoyed an 18% uplift in net gaming revenue in 2021, outperforming group net gaming revenue of 12%.

The impact of regulatory changes in the UK was responsible for slow group online net gaming revenue which dipped 1%.

“Entain has been facing mounting investor pressure, and rising player protection measures in Europe are not going to help. The business opportunity in America looks much brighter.”

“Nebraska and Maine are likely to go live by H2 2023. Georgia, Kentucky, and Minnesota are possibilities, whereas Missouri and North Carolina could stall. This could deliver 15-20% TAM growth.”

“Entain’s biggest opportunity is in the online sports betting space. The Super Bowl betting record proves huge potential. Our experts say that Entain also needs to move beyond the NFL season and capitalize on other events throughout the annual sporting calendar.” 

Aviva shares jump as profit beats expectations

Aviva shares perked up on Thursday after the insurance and wealth firm said operating profit surged 35% to £2.2bn smashing analyst expectations.

Unlike some of their competitors, Aviva has managed to keep a lid on costs are carve out an increase in operating profit. However, Aviva was hit the same market swings as their peers and recorded an overall loss for the year due to adverse changes in investments.

Nonetheless, an increase in insurance premiums net of reinsurance helped operating profits higher and investors cheered the news sending Aviva shares over 3% to the good.

Aviva is regarded by many as a pillar of their income portfolio and today’s announcement reinforced this assertion with a final dividend hike to 20.7p to total 31p for the 2022 full year. This is sharp increase on 2021’s 22.05p pay out.

The firm will also commit an additional £300m to share buybacks meaning Aviva has returned £5bn to investors since 2021.

“Aviva’s the latest insurer to push through hefty hikes for its general insurance premiums, a trend expected to continue over 2023 as the cost to service claims has risen in this inflationary environment,” said Matt Britzman, equity analyst at Hargreaves Lansdown.

“The tricky backdrop pushed underwriting profitability down a touch, but the diversified model showed its strengths as performance on the whole was resilient. The life insurance business should be able to benefit from the growing number of pension schemes that now find themselves in the position of being able to de-risk – we’d expect to see an uptick in bulk purchase annuity business over the coming year as a result.”

“For investors, news of a £300m buyback was welcomed with open arms – the capital position remains strong, and the potential for further buybacks alongside a 7.8% forward yield looks attractive.”

Canadian Overseas Petroleum – have the shares been oversold?

In the last few weeks there has been a considerable amount of investor interest built up in this company, especially since the issue in January this year of its 336-page document for listing new shares on the Official List.

With its Head Office in Calgary, Alberta the £20m capitalised Canadian Overseas Petroleum (LON:COPL) is engaged in the exploration, appraisal, development and production of oil and gas assets with producing assets and reserves principally in the Converse and Natrona Counties in the US state of Wyoming, where it is the operator and majority working interest owner of three oil producing units.

The Wyoming operations are environmentally responsible with minimal gas flaring and methane emissions combined with electricity sourced from a neighbouring wind farm to power production facilities.

The group also has interests in sub-Saharan Africa through its ShoreCan joint venture in Essar Nigeria, as well as independent interests in other countries.

The ‘game changer’

However, the ‘game changer’ was declared by the company in late December 2022. 

That was at its Frontier 1 11-27 recompletion which has been defined as the oil-bearing reservoir covering a large area at its Cole Creek asymmetrical anticline, some 9 miles in axial length with around 2,500 feet of structural/stratigraphic closure.

There are five known conventional oil reservoirs at Cole Creek – Lakota, Dakota, Frontier 2, Frontier 1 and the Shannon. The group has a 100% working interest in the Cole Creek leasehold on all rights below the Shannon.

An ‘Oil Down To’ elevation at the base of the Frontier 1 perforations has been determined. This elevation is some 760′ below the crestal elevation of the Cole Creek Anticline. The area within the ‘Oil Down To’ elevation is about 8,000 acres with reservoir sand thickness ranging from 50-115′, thinning in the northern area. 

In late January the announced the first oil production from the Frontier 1 reservoir sands.

In an Operations Update issued at the start of March the company reported that severe winter storms from late December to late February had impacted production operations at its Barron Flats Shannon Unit and its Cole Creek field.

The high winds, very low temperatures and drifting snow caused it to suspend operations during the storms. 

The Group’s Strategy

The strategy of the group has two key elements: the first is to accelerate production at the company’s Wyoming assets through increased gas injection, drilling and development; the second is to expand its activities in Sub-Saharan Africa and elsewhere by accessing exploration, un-appraised and undeveloped assets as well as producing assets.

Conclusion – taking a positive out of the negative

Some 19 pages in the early part of the Prospectus were Risk Factors, negatively covering almost every eventuality.

In the last year the shares of have fallen 85% from 39p to around the current 5.9p, the big question now is – are the shares oversold?

Flat revenues at Somero Enterprises

1

A slowing of demand in the US meant that the overall revenues of AIM-quoted Somero Enterprises Inc (LON: SOM) were flat last year even though Europe and Australia performed well. Additional overheads meant that profit declined.  

US-based Somero Enterprises Inc designs, assembles and supplies concrete levelling equipment. North America is the key market for the business and problems with concrete deliveries hampered sales.  

Australia is benefiting from direct sales. A strong second half meant that European revenues reached a new peak. India is a country where revenues are building up, although China is a tougher market with declining income.

In 2022, revenues edged ahead to $133.6m, while pre-tax profit dipped from $46.5m to $42.3m. Higher overheads reduced the profit. Investment has been put in place to help Somero Enterprises to grow in the future. The new Houghton, Michigan facility will open this year.

The dividend based on profit remains twice covered by earnings. The standard dividend total is 27.78 cents a share, while the special dividend is 7.7 cents a share. Both types of dividends are lower than for 2021. The total has fallen from 50.72 cents a share to 35.48 cents a share. Even with another special dividend next year, the total dividend is expected to be 31 cents a share for 2023.

Net cash fell to $33.7m at the end of 2022 because of the high dividend payments during the year. It could be $31m by the end of 2023.

finnCap forecasts a further decline in pre-tax profit to $39.3m. That is likely to lead to a reduction in dividend to 31 cents a share.

At 377p, the prospective multiple is less than nine. The potential dividend yield is nearly 7%.

Cloud accelerates Netcall progress

0

Customer engagement and intelligent automation systems supplier Netcall (LON:NET) is involved in a global process automation market that is estimated to be growing at 20% a year. The company’s cloud-based annual contract revenues grew by 58% to £17.1m in the first half.

In the six months to December 2022, group revenues grew by 19% to £17.5m, while better margins meant that underlying pre-tax profit jumped from £1.91m to £3.19m. Net cash has reached £20.4m – one-eighth of market capitalisation.

Cloud-based products account for more than four-fifths of new product sales. The main health and government markets are growing.

There could be opportunities to accelerate growth through acquisitions that broaden the technology or take the company into new geographic markets. There is plenty of cash to finance any deals if they can be done at the right price.

Singer has been appointed as joint broker. Canaccord Genuity forecasts an increase in pre-tax profit from £3.9m to £5.7m. At 102.5p, the shares are trading on 35 times prospective earnings, falling to 29 next year. The forecast dividend of 0.7p a share would be more than four times covered by earnings.  

Breedon plans premium move

0

Aggregates and cement supplier Breedon (LON: BRE) is planning to move from AIM to a premier listing and it is large enough to be included in the FTSE 250 index when a space becomes available. This will bring new investors to the company, particularly index tracker funds that will need to take a shareholding.

Breedon started out as a shell on AIM in June 2008 when it was known as Marwyn Materials and through acquisitions it has been built up into a company with a market capitalisation of £1.28bn at 75.5p. The initial subscription price was 10p and the starting market capitalisation was £13.6m.  

Volumes declined from their unusually high levels in 2021, but higher prices meant that revenues improved from £1.23bn to £1.4bn. Underlying pre-tax profit increased from £120.5m to £142.8m, while the dividend was raised from 1.6p a share to 2.1p a share. Net debt is £197.7m.

Although volumes fell, they are still well above the level in 2019. The growth in profit came from Great Britain with a flat contribution from Ireland.

Capital investment is significant although it is well covered by cash generation. There were small add-on acquisitions last year and Breedon is still interested in purchases that fill in gaps in its business. Longer-term, acquisitions could be made in North America.

The new financial year has started well with continued strong demand from infrastructure products. Breedon is less exposed to the weak residential market. Even so, profit is likely to decline this year putting the shares on just over 13 times prospective earnings.

No date has been set for the move to the premium listing. As part of the move a new England-based holding company will be set up to replace the current Channel Islands one and there will be a share consolidation.

AIM movers: Time Finance gains momentum and Midatech Pharma to leave AIM

1

Small business finance provider Time Finance (LON: TIME) appears to be gaining momentum. Third quarter trading figures have sparked a full year pre-tax profit upgrade by Cenkos from £3.2m to £3.6m. In the latest nine month period the pre-tax profit is £3m, up from £1.1m, so this is an achievable forecast. Arrears are low at 6% and the gross loan book is worth £157.2m. The share price moved 15.7% higher at 25.8p.

Pantheon Resource (LON: PANR) has recovered some of its loss from earlier in the week following disappointing flow test results from the Alkaid #2 well in Alaska. The share price improved by 21% to 28.54p. The share price has still nearly halved this week.

Clean water technology company MyCelx Technologies Corp (LON: MYX) has secured a second pilot testing agreement for treatment of PFAS in landfill leachate in the US. The aim is to remove chemicals to non-detectable concentrations. The share price increased 9.52% to 34.5p.

Ovoca Bio (LON: OVB) is selling its Russian assets to Desirix for €1.05m. This includes Russian patents for Orenetide, plus certain development and marketing rights. Ovoca Bio will continue the development and trialling of Orenetide, a treatment for hypoactive sexual desire disorder, in other markets. The share price rose 6.67% to 6p.  

Midatech Pharma (LON: MTPH) has posted a circular about its proposed share consolidation and cancellation of the AIM quotation. The current share price fell 19.4% to 1.25p. There will be a 20-for-one share consolidation and that would make the ADSs listed on Nasdaq more attractive to US investors and remove the worries concerning being thrown off Nasdaq for having a price below $1. Currently, one ADS represents 25 shares and after the consolidation it will represent five shares. The company’s name will be changed to Biodexa Pharmaceuticals.

Redx Pharma (LON: REDX) has revealed topline data for the biliary tract cancer module of the RXC004 PORCUPINE2 phase two clinical trial. The results were not good enough to further develop RXC004 as a monotherapy. There is still potential as part of a combination therapy. The share price fell 18.3% to 33.5p.

musicMagpie (LON: MMAG) released 2021-2022 figures in line with the recent trading statement. December was difficult because of the postal strikes, but trading has improved since the beginning of the year. Shore forecasts an increase in 2022-23 loss from £1m to £1.5m, even though revenues should grow, with net debt increasing from £7.9m to £12.9m. The share price slipped by 9.6% to 33.9p. The April 2021 flotation price was 193p.

Red Rock Resources (LON: RRR) is making progress in commencing lithium production in Zimbabwe. This will initially be from the Tin Hill project with production from Beatrice likely to start later. A target grade of 2% lithium will be sold in the local market. Partners in New Ballarat Gold are seeking a listing. The listing of Elephant Oil has taken longer than expected. The share price fell 9.68% to 0.28p.

FTSE 100 recovers early losses as interest rate concerns hit stocks

The FTSE 100 recovered early losses on Wednesday after a terrible session overnight in the US sparked by interest rate concerns following Federal Reserve chair Powell’s hawkish testimony to Congress.

Jay Powell struck a hawkish tone in his delivery and suggested markets should prepare for more 50bps rate hikes, and for rates to remain higher for longer.

“The broad-based rally in stock and bond markets since the October lows rests largely upon their conviction that inflation will retreat, the global economy will suffer no more than a shallow recession (or even avoid a downturn altogether) and central banks will be able to start cutting interest rates sooner rather than later as a result,” said AJ Bell investment director Russ Mould.

“The statement from US Federal Reserve chair Jay Powell to the Senate Banking Committee in Washington on Tuesday challenges this oh-so-cosy consensus and that is why stock markets are stumbling.”

The FTSE 100 was trading at 7,916 at the time of writing, down just 2 points. The index touched lows of 7,891 earlier in the session. The S&P 500 was down around 1.5% overnight in a market reaction to a hawkish Fed chair that was to be expected.

Hiscox

Hiscox was the FTSE 100’s top riser after their gross premiums and premiums written rose in 2022. Poor investment results meant profit before tax fell, but delivery on their strategy ultimately helped shares higher.

“I am very pleased with the progress made across the Group during 2022, as we delivered the strongest underwriting result in seven years. We have a refined strategy, a new experienced and energetic leadership team, we have made significant progress in rolling out new-generation technology in the USA and Europe and we are enjoying our highest employee engagement scores in ten years,” said Aki Hussain, Group Chief Executive Officer, Hiscox.

Hiscox shares were 3.5% higher at the time of writing.

Schroders was the top faller, down 3.4%, after peer Legal & General reported their full year results and provided an insight into the damage Liz Truss’s doomed mini-budget did to their investment business. Legal & General were 2% lower. Schroders reported their results earlier in March.

Legal & General investors book profits after strong 2022 results confirmed

Legal & General investors booked profits on Wednesday as the company confirmed positive results for 2022 which included a 12% jump in operating profit and a 5% dividend hike to 19.37p.

Legal & General shares were 2% lower on Wednesday after the company’s shares yesterday touched the highest level since the Liz Truss Gilt debacle last year.

L&G shares are roughly 30% higher from the intraday lows recorded in October 2022.

Their higher group operating profit pays testament to L&G’s risk management as they successfully navigated the mini-budget gilt market volatility without suffering a significant level of disruption to their investment business. Legal & General Investment Management operating profit slipped 19% to £340m and Assets under management also fell.

Despite weakness in the investment management business, Legal & General’s cash generation rose 14% to £1.9bn.

“The outlook for the group looks positive, regardless of the impact of last year’s bond market rout. The group are bringing in new assets at pace and pension funds are increasingly looking to L&G to assume their liabilities in exchange for substantial premiums. The group’s Capital business is growing strongly and has maintained asset quality at high levels to date,” said Steve Clayton, Head of Equity Funds at Hargreaves Lansdown.

“The dividend is set to rise 5% this year and next, in line with the group’s stated policy. That puts L&G onto a yield of approaching 7.8%. It is rare to find businesses that can sustain that level of dividend pay-out, but in L&G’s case, the dividend is well covered by earnings and capital generation.”